Caliway Biopharmaceuticals (TWSE: 6919) announced that preclinical data on its drug candidate CBL-514 combined with GLP-1R agonists has been selected ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE